Since NGF deficits have been described in diabetic neuropathy (Anand et al., 1996, Hellweg and Hartung, 1990) we propose that reduced MMP-2 levels may directly alter the availability of active neurotrophins in diabetes. This evidence concerns the gene NGF and diabetic neuropathy.